JAMA Medical News

As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss; Implementation Science Seeks to Translate Research Into Practice; What a Study of Hibernating Bears Tells Us About Deep Vein Thrombosis Related Content: As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide and Weight Loss It Takes an Average of 17 Years for Evidence to Change Practice—the Burgeoning Field of Implementation Science Seeks to Speed Things Up What a Study of Hibernating Bears Tells Us About Deep Vein Thrombosis

Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession—Even If It Doesn’t Become Law; The Debate Over Whether to Make Daylight Saving or Standard Time Permanent; Expanded Family Leave Policies May Ease Burden for Residents Related Content: Physicians Say an Idaho House Bill That Would Criminalize Administering mRNA Vaccines Is an Attack on the Medical Profession—Even If It Doesn’t Become Law Groundswell Grows for Permanent Daylight Saving Time, but Medical Societies Overwhelmingly Support Year-Round Standard Time Expanded Family Leave Policies May Ease Burden for Residents Cut Calories, Lengthen Life Span? Randomized Trial Uncovers Evidence That Calorie Restriction Might Slow Aging, but Questions Remain Highlights From the American College of Cardiology’s 2023 Scientific Session: the Ketogenic Diet and Cardiac Events, a Wearable Sensor to Predict Troponin Levels, Bempedoic Acid for Statin Intolerance, and More Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C

JAMA Medical News Senior Staff Writer Melissa Suran, PhD, MSJ, speaks with Douglas Drachman, MD, about late-breaking research discussed at the annual conference of the American College of Cardiology and World Congress of Cardiology. Dr Drachman—who chaired this year’s conference—is an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division. Related Content: Highlights From the American College of Cardiology’s 2023 Scientific Session: the Ketogenic Diet and Cardiac Events, a Wearable Sensor to Predict Troponin Levels, Bempedoic Acid for Statin Intolerance, and More

More than 2 million individuals in the US are chronically infected with hepatitis C, and nearly 15 000 die every year. Antivirals are available but are not reaching the majority of infected individuals. In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Francis S. Collins, MD, PhD, discuss a plan to eliminate hepatitis C included in the Biden-Harris 2024 budget proposal. Related Content: A National Hepatitis C Elimination Program in the United States Eliminating Hepatitis C in the United States Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C After 12 Years, NIH Director Francis S. Collins, MD, PhD, Seeks His Next Chapter After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter

Conference clinical cochair Diane Havlir, MD, a professor of medicine at the University of California, San Francisco, sits down with JAMA Deputy Editor Preeti Malani, MD, MSJ, about research highlights presented at the 30th annual CROI, held in Seattle. The infectious disease experts discuss postexposure prophylaxis for sexually transmitted infections, a new protease inhibitor for COVID-19, goals for preventing HIV transmission, and more. Related Content: Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections—Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More

Bird Flu Has Begun to Spread in Mammals—Here’s What’s Important to Know; Questions Remain About What Should Go Into Annual COVID-19 Vaccines; Long COVID Linked With Unemployment in New Analysis; As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers’ Interest. Related Content: Bird Flu Has Begun to Spread in Mammals—Here’s What’s Important to Know Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA Long COVID Linked With Unemployment in New Analysis As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers’ Interest

We’re revisiting this 2017 episode—with updates! The episode is an interview with Robert T. "Chip" Schooley, MD, a professor of medicine in the Division of Infectious Diseases and Global Public Health at the University of California, San Diego, and codirector of the school’s Center for Innovative Phage Applications and Therapeutics. Dr Schooley discusses the unique events that led to the first use of intravenous phage therapy in North America. Stay tuned to the end for an update on phage therapy and on Thomas Patterson, the patient who received the lifesaving treatment. Related Content: Phage Therapy’s Role in Combating Antibiotic-Resistant Pathogens As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers’ Interest

Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection; From Thought to Text: How an Endovascular Brain-Computer Interface Could Help Patients With Severe Paralysis Communicate Related Content: Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection From Thought to Text: How an Endovascular Brain-Computer Interface Could Help Patients With Severe Paralysis Communicate Swab the Throat as Well as the Nose? The Debate Over the Best Way to Test for SARS-CoV-2 Study: Short Spurts of Vigorous Physical Activity During Daily Life Are Associated With Lower Mortality Ceasefire Declared, but Ethiopian Health Systems Remain in Critical Condition After Civil War

Telemedicine Rollbacks—Why Providing Care Across State Lines Is No Longer as Simple as It Was Early in the Pandemic; Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic; Will the New CDC Opioid Prescribing Guidelines Help Correct the Course in Pain Care? Related Content: Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic Will the New CDC Opioid Prescribing Guidelines Help Correct the Course in Pain Care?

Trying to Predict What the COVID-19 Pandemic Might Look Like This Winter in the US; “This Is Our COVID”—What Physicians Need to Know About the Pediatric RSV Surge; Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People. Related Content: How Immune-Evasive Omicron Offspring and a Lack of Mitigation Measures Could Shape a COVID-19 Winter Wave “This Is Our COVID”—What Physicians Need to Know About the Pediatric RSV Surge Conflict and Climate Collide to Create an Acute Hunger Crisis for an Unprecedented 345 Million People Highlights From the American Heart Association’s Scientific Sessions 2022—COVID-19’s Ripple Effects, a Triglyceride Disappointment, Gene Editing Advances, and More Highlights From Infectious Disease Week 2022—COVID-19, HIV, Monkeypox, and Polio After the First Pig-to-Human Heart Transplant, Scientists Look to the Future of Cardiac Xenotransplantation Detailed Maternal Mortality Data Suggest More Than 4 in 5 Pregnancy-Related Deaths in US Are Preventable